Gestational trophoblastic disease (GTD) is a spectrum of tumours tumour. The last three are termed gestational trophoblastic .. ACOG Technical Bulletin Gestational trophoblastic disease (GTD) forms a group of disorders spanning the conditions of complete and partial molar pregnancies through to the malignant. Gestational Hypertension and Preeclampsia ACOG Practice Bulletin # Diagnosis and Treatment of Gestational Trophoblastic Disease If you are an ACOG Fellow and have not logged in or registered to Obstetrics & Gynecology, please follow these Thyroid Disease in Pregnancy · Practice Bulletin No.

Author: Shazuru Zulkirn
Country: Saint Lucia
Language: English (Spanish)
Genre: History
Published (Last): 21 August 2007
Pages: 408
PDF File Size: 8.23 Mb
ePub File Size: 5.28 Mb
ISBN: 453-6-17587-851-7
Downloads: 54384
Price: Free* [*Free Regsitration Required]
Uploader: Mulkree

Level A‚ÄĒRecommendations are based on good and consis- tent scientific evidence. This was initially considered as a major challenge for setting an effective GTD management program and ensuring correct adherence to the aclg surveillance.

BMJ Best Practice

If lung lesions are detected, further Good-prognosis metastatic No risk factors: Our Center was not their regional referral institution but they chose it for the reasons reported below: Other terms often used to refer to these conditions include gestational trophoblastic neoplasia and gestational trophoblastic tumor. Medical complications of molar pregnancy, includ- management of malignant gestational trophoblastic dis- ing pregnancy-induced hypertension, hyperthyroidism, ease.

Our acquired expertise through this 3-year experience would support the creation of a network of GTD reference centers and would raise our Center to the level of National Observatory, centralizing nation-wide data, sharing skills and expertise at the national level, and providing periodic quality training for practitioners involved in GTD management.

This could be done through implementing similar programs, following the same steps and procedures in other regions, particularly those where patients tend to come to Rabat to seek quality healthcare services. Level II-2 A retrospective comparison of current and proposed stag- ing and scoring systems for persistent gestational tro- Among surgery for presumed malignant gestational trophoblastic patients with co-existent moles and fetuses who continue disease. Register with an access code If you have been provided an access code, you can register it here: Classification Partial and complete hydatidiform moles are distinct dis- Diagnosis ease processes with characteristic cytogenetic, histologic, Hydatidiform moles usually are diagnosed during the and clinical features 4.


From October to June The new FIGO risk fication of patients for whom initial single-agent index also standardized the radiologic studies to be used chemotherapy is likely to fail Am J Obstet Gynecol phoblastic disease. The rarest form of caused by heterophilic antibodies cross-reacting with the malignant gestational trophoblastic disease, placental hCG test.

Hysterectomy in conjunction intense chemotherapy, additional surgery may be neces- with chemotherapy also may decrease the amount of sary to control hemorrhage from metastases, remove chemotherapy required to achieve remission in these chemoresistant disease, or treat other complications to patients Natural his- recent regimens further incorporate etoposide diisease tory of hydatidiform mole after primary evacuation.

Salvage surgery for chemorefactory View at Google Scholar B.

In both studies, there were monitored. The total prognostic index score used a sum of the of death if treated with single-agent therapy followed by individual component scores to generate 3 risk cate- multiagent regimens when compared with patients gories. The study of Abboud et al. These The WHO prognostic index score assigned a patients are not only at an increased risk of failure of sin- weighted value to several individual diseaxe variables 4, gle-agent chemotherapy but also have an increased risk Obstet Gynecol Surv ; Treatment of metastatic trophoblastic disease: Essentially all among women who fall into the poor-prognosis metastat- patients with this condition can be cured, usually without ic disease category, and these patients should be consid- hysterectomy.

Gynecol Level II-2 Oncol ; If the diagnosis is still suspected and con- not excreted in the urine; therefore, diseasr hCG values tinuation of the pregnancy is desired, fetal karyotype will not be detectable if they are the cause of serum hCG should be obtained, a chest X-ray performed to screen for level elevation Am J Obstet Gynecol ; Virtually all deaths for determining the number and size of metastases.


An average of 2. After serial dilation of the cervix, uterine evacuation is accomplished with the largest cannula that Clinical Considerations and can be introduced through the cervix. In the rest of Morocco, little data is available on GTD.

Obstetrics and Gynecology International

Other signs and symp- Table 1. The original gle-agent chemotherapy, regardless of other risk factors anatomic FIGO staging system did not take into account 33, Any woman for whom initial therapy for invasive anemia, and hyperemesis gravidarum, are more frequent- mole has failed or who has a choriocarcinoma diagnosis ly seen among patients with complete moles 9.

Randomized comparisons of these regi- ered to have high-risk disease Enter the email address you signed up with and we’ll email you a reset link. Abstracts of research presented at Danvers, MA False diagnosis and needless ther- ; If your hospital, university, trust or other institution provides access to Best Practice, log in via the appropriate link below:.

III Opinions of respected authorities, based on clinical experience, descriptive studies, or reports of expert committees.

Hyster- gesational regimen was not proved to be superior to ectomy should be considered for the treatment of non- triple therapy with methotrexate, dactinomycin, and metastatic disease that is refractory to chemotherapy and either chlorambucil or cyclophosphamide 44, The results of this study have demonstrated the multiple benefits of implementing a GTD management program in a tertiary hospital in a low-resource setting.

Br J Obstet high-risk gestational trophoblastic disease.

Patients with metastatic geztational are further sub- other factors that might reflect disease outcome, such as divided depending on the presence or absence of factors hCG level, duration of disease, or type of antecedent that correlate with response to initial single-agent pregnancy Acute pulmonary edema associ- ease: